Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

$24.99

Analysis of Revenues

Microsoft Excel

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Johnson & Johnson for $24.99, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Revenues as Reported

Johnson & Johnson, income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 29, 2019
Innovative Medicine
MedTech
Sales to customers

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29).

Item Description The company
Sales to customers Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Johnson & Johnson sales to customers increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.